CO-NEBILET 5mg / 12.5mg film-coated tablets medication leaflet

C07BB12 nebivolol + hydrochlorothiazide • Cardiovascular system | Beta blocking agents and thiazides | Beta blocking agents, selective, and thiazides

Nebivolol and hydrochlorothiazide are used together to treat high blood pressure (hypertension). Nebivolol is a beta-blocker that helps relax blood vessels and reduce heart rate, thereby lowering blood pressure. Hydrochlorothiazide is a diuretic that helps remove excess water and salt from the body, reducing blood volume and blood pressure.

This combination is effective in reducing the risk of cardiovascular complications, such as heart attacks and strokes, in patients with hypertension. It is important to take the medication as prescribed by your doctor to achieve the best results.

Nebivolol is well-tolerated by most patients but may cause side effects such as fatigue, dizziness, or headaches. Hydrochlorothiazide may lead to potassium loss, requiring regular monitoring of electrolyte levels.

Patients should inform their doctor about any other medications they are taking, as this combination may interact with other treatments. Additionally, maintaining a healthy lifestyle, including a balanced diet and regular exercise, is essential to support the treatment of high blood pressure.

General data about CO-NEBILET 5mg / 12.5mg

Substance: nebivolol + hydrochlorothiazide

Date of last drug list: 01-04-2026

Commercial code: W54259002

Concentration: 5mg / 12.5mg

Pharmaceutical form: film-coated tablets

Quantity: 14

Product type: original

Price: 18.94 RON

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: BERLIN - CHEMIE AG - GERMANIA

Holder: MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. - LUXEMBURG

Number: 5382/2013/02

Shelf life: 3 years

Concentrations available for nebivolol + hydrochlorothiazide

5mg/12.5mg, 5mg/25mg